NCT06104696 Comprehensive Geriatric Assessment in Kidney Transplantation
| NCT ID | NCT06104696 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institute for Clinical and Experimental Medicine |
| Condition | Kidney Transplant; Complications |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2020-01-02 |
| Primary Completion | 2025-01-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2020-01-02 with a primary completion date of 2025-01-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This observational study aims to analyze the results of comprehensive geriatric assessment and to monitor the development of functional status in geriatric kidney transplant candidates and recipients.
Eligibility Criteria
Inclusion Criteria: * kidney transplant candidates aged 60+ years * kidney transplant recipients aged 60+ years Exclusion Criteria: * kidney transplant candidates aged below 60 years * kidney transplant recipients aged below 60 years
Contact & Investigator
Silvie Rajnochova Bloudickova, MD,PhD
STUDY DIRECTOR
Department of Nephrology, Institute for Clinical and Experimental Medicine
Frequently Asked Questions
Who can join the NCT06104696 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Kidney Transplant; Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06104696 currently recruiting?
Yes, NCT06104696 is actively recruiting participants. Contact the research team at sibl@ikem.cz for enrollment information.
Where is the NCT06104696 trial being conducted?
This trial is being conducted at Prague, Czechia.
Who is sponsoring the NCT06104696 clinical trial?
NCT06104696 is sponsored by Institute for Clinical and Experimental Medicine. The principal investigator is Silvie Rajnochova Bloudickova, MD,PhD at Department of Nephrology, Institute for Clinical and Experimental Medicine. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.